Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 27 04:00PM ET
0.9299
Dollar change
+0.0399
Percentage change
4.48
%
Index- P/E- EPS (ttm)-0.63 Insider Own11.82% Shs Outstand54.24M Perf Week7.05%
Market Cap48.55M Forward P/E- EPS next Y-0.24 Insider Trans3.86% Shs Float46.04M Perf Month-3.14%
Income-28.51M PEG- EPS next Q-0.12 Inst Own35.96% Short Float3.63% Perf Quarter-45.94%
Sales36.35M P/S1.34 EPS this Y20.83% Inst Trans-2.91% Short Ratio5.52 Perf Half Y-50.01%
Book/sh0.43 P/B2.17 EPS next Y53.29% ROA-47.43% Short Interest1.67M Perf Year-71.56%
Cash/sh0.27 P/C3.44 EPS next 5Y- ROE-97.21% 52W Range0.84 - 4.29 Perf YTD-16.23%
Dividend Est.- P/FCF- EPS past 5Y-2.64% ROI-73.63% 52W High-78.32% Beta0.58
Dividend TTM- Quick Ratio1.51 Sales past 5Y13.13% Gross Margin61.60% 52W Low10.70% ATR (14)0.06
Dividend Ex-Date- Current Ratio1.77 EPS Y/Y TTM15.74% Oper. Margin-83.87% RSI (14)46.97 Volatility5.88% 6.92%
Employees186 Debt/Eq0.79 Sales Y/Y TTM4.79% Profit Margin-78.43% Recom1.67 Target Price2.67
Option/ShortYes / Yes LT Debt/Eq0.66 EPS Q/Q-581.82% Payout- Rel Volume0.28 Prev Close0.89
Sales Surprise-6.20% EPS Surprise12.73% Sales Q/Q-7.69% EarningsMar 14 AMC Avg Volume302.64K Price0.93
SMA20-2.18% SMA50-4.57% SMA200-51.58% Trades Volume84,247 Change4.48%
Date Action Analyst Rating Change Price Target Change
Sep-07-23Initiated B. Riley Securities Buy $4
Oct-14-21Resumed B. Riley Securities Buy $10
Sep-17-20Initiated Jefferies Buy $15
Sep-01-20Initiated SVB Leerink Outperform $15
Aug-08-17Reiterated Maxim Group Buy $10 → $12
Oct-26-16Initiated Aegis Capital Buy
May-24-16Initiated Maxim Group Buy $8
Oct-29-15Upgrade WBB Securities Speculative Buy → Buy $13 → $13
May-12-15Reiterated MLV & Co Buy $28 → $21
Apr-01-15Reiterated MLV & Co Buy $28 → $30
Mar-15-24 10:14AM
06:28AM
Mar-14-24 09:53PM
04:39PM
Mar-06-24 07:00AM
07:00AM Loading…
Feb-08-24 07:00AM
Jan-17-24 07:15AM
Dec-28-23 07:00AM
Dec-16-23 07:01AM
Dec-13-23 09:15AM
Nov-10-23 09:42AM
08:52AM
Nov-09-23 05:47PM
04:15PM
Oct-27-23 07:00AM
07:00AM Loading…
Oct-05-23 07:00AM
Sep-27-23 07:00AM
Sep-21-23 09:35AM
Sep-19-23 07:00AM
Sep-11-23 11:32AM
Sep-01-23 04:43PM
Aug-31-23 07:00AM
Aug-14-23 07:00AM
Aug-03-23 09:10AM
Aug-02-23 09:02AM
Aug-01-23 04:23PM
04:15PM
Jul-31-23 07:31AM
Jul-26-23 07:00AM
Jul-19-23 07:00AM
07:00AM Loading…
Jul-11-23 07:00AM
Jul-09-23 09:00AM
Jul-07-23 07:07AM
Jun-15-23 07:00AM
Jun-05-23 09:00AM
May-05-23 07:18AM
May-04-23 10:31AM
May-03-23 07:42AM
May-02-23 04:23PM
04:15PM
Apr-26-23 07:00AM
Apr-20-23 07:00AM
Apr-19-23 07:00AM
Apr-17-23 10:47AM
Mar-29-23 08:30AM
Mar-22-23 08:09AM
Mar-20-23 07:38AM
Mar-17-23 09:10AM
Mar-14-23 07:00AM
Mar-13-23 02:53AM
Mar-10-23 10:33AM
Mar-09-23 04:15PM
Mar-07-23 07:00AM
Feb-27-23 07:00AM
Feb-24-23 07:00AM
Feb-21-23 06:22AM
Feb-15-23 08:20AM
Jan-31-23 07:15AM
Jan-29-23 09:58AM
Jan-23-23 07:00AM
Jan-17-23 07:00AM
Jan-12-23 07:16AM
Dec-29-22 07:00AM
Dec-21-22 07:00AM
Nov-17-22 05:21AM
Nov-14-22 07:00AM
Nov-09-22 05:26AM
Nov-03-22 08:15PM
04:15PM
Nov-02-22 07:10AM
Oct-31-22 07:00AM
Oct-27-22 07:00AM
Oct-25-22 07:32AM
Oct-12-22 07:00AM
Oct-07-22 07:05AM
Oct-06-22 11:12AM
07:00AM
Oct-04-22 01:42PM
07:00AM
Sep-27-22 08:20AM
Sep-14-22 06:39AM
Sep-09-22 07:00AM
Sep-07-22 07:30AM
Aug-23-22 07:02AM
Aug-17-22 07:02AM
Aug-08-22 06:09AM
Aug-05-22 07:40AM
Aug-02-22 06:35PM
04:17PM
04:15PM
Jul-25-22 07:00AM
Jul-08-22 08:44AM
Jul-01-22 07:00AM
Jun-24-22 06:23AM
Jun-02-22 07:00AM
Jun-01-22 07:00AM
May-19-22 07:00AM
May-12-22 11:58AM
May-03-22 04:15PM
May-02-22 07:00AM
CytoSorbents Corp. engages in critical care immunotherapy, investigation, and commercialization of blood purification technology. Its product portfolio includes CytoSorb, ContrastSorb XL, HemoDefend, VetResQ, and DrugSorb. The company was founded by Joseph Rubin in August 1997 and is headquartered in Princeton, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Chan Phillip P.Chief Executive OfficerDec 13 '23Buy1.3375,188100,0001,068,704Dec 15 04:30 PM
BATOR MICHAEL G.DirectorDec 13 '23Buy1.3337,59450,000125,394Dec 15 04:33 PM
BLOCH KATHLEEN P.Chief Financial OfficerDec 13 '23Buy1.3337,59450,000467,941Dec 15 04:32 PM
Deliargyris EfthymiosChief Medical OfficerDec 13 '23Buy1.3322,55730,001348,433Dec 15 04:34 PM
Sobel Alan D.DirectorDec 13 '23Buy1.3322,55730,001101,857Dec 15 04:35 PM
Capponi VincentPresident & COODec 13 '23Buy1.3318,79725,000584,134Dec 15 04:34 PM
Kim JinyDirectorDec 13 '23Buy1.337,51910,00077,819Dec 15 04:31 PM
Jones Edward RaymondDirectorDec 13 '23Buy1.337,51910,00088,834Dec 15 04:32 PM
BATOR MICHAEL G.DirectorAug 07 '23Buy3.172,0006,35087,800Aug 08 08:01 PM
BATOR MICHAEL G.DirectorAug 04 '23Buy3.231,0003,23085,800Aug 08 08:01 PM
BLOCH KATHLEEN P.Interim CFOMay 25 '23Buy2.853,3009,38947,000May 30 07:30 AM
BLOCH KATHLEEN P.Interim CFOMay 10 '23Buy3.1110,00031,05843,700May 12 07:00 AM
Capponi VincentSee RemarksApr 04 '23Option Exercise2.8810,00028,750511,989Apr 05 07:06 PM
Chan Phillip P.Chief Executive OfficerApr 03 '23Option Exercise2.8830,50087,688927,779Apr 05 05:00 PM